Obsessive-compulsive symptoms in patients with schizophrenia: A naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients

Journal of Clinical Psychiatry

Volumn 73, Issue 11, 2012, Pages 1395-1402

  Scheltema Beduin, Albertine A ^a   Swets, Marije ^b   Machielsen, Marise ^a   Korver, Nikie ^a   Kahn, René S ^c   Linszen, Don H ^c   Van Os, Jim ^c   Wiersma, Durk ^c   Bruggeman, Richard ^c   Cahn, Wiepke ^c   De Haan, Lieuwe ^a   Krabbendam, Lydia ^c   Myin Germeys, Inez ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Arkin Mental Health and Addiction Treatment Centre   (Netherlands)

^c Academic Psychiatric Centre ^*

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84869236776     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07164     Document Type: Article

References (73)

1. Gordon A. Obsessions in their relation to psychosis. Am J Psychiatry. 1926;82:647-659.
2. Berman I, Kalinowski A, Berman SM, et al. Obsessive and compulsive symptoms in chronic schizophrenia. Compr Psychiatry. 1995;36(1):6-10. doi:10.1016/010-40X(95)9092-A PubMed
3. Berman I, Merson A, Viegner B, et al. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. J Nerv Ment Dis. 1998;186(3):150-156. doi:10.1097/05053-198030-03 PubMed (Pubitemid 28124329)
4. Kayahan B, Ozturk O, Veznedaroglu B, et al. Obsessive-compulsive symptoms in schizophrenia: prevalence and clinical correlates. Psychiatry Clin Neurosci. 2005;59(3):291-295.doi:10.1/j.140-1819.205.01373.x PubMed (Pubitemid 40897200)
5. Nechmad A, Ratzoni G, Poyurovsky M, et al. Obsessive-compulsive disorder in adolescent schizophrenia patients. Am J Psychiatry. 2003;160(5):1002-1004. doi:10.176/api.ajp.160.5.102 PubMed (Pubitemid 41079590)
6. Eisen JL, Beer DA, Pato MT, et al. Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder. Am J Psychiatry. 1997;154(2):271-273. PubMed (Pubitemid 27053739)
7. Ohta M, Kokai M, Morita Y. Features of obsessive-compulsive disorder in patients primarily diagnosed with schizophrenia. Psychiatry Clin Neurosci. 2003;57(1):67-74. doi:10.1046/j.140-1819.203.01081.x PubMed (Pubitemid 36227551)
8. Poyurovsky M, Hramenkov S, Isakov V, et al. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Res. 2001;102(1):49-57. (Pubitemid 32463924)
9. Krüger S, Bräunig P, Höffler J, et al. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci. 2000;12(1):16-24. PubMed (Pubitemid 30093684)
10. Fullana MA, Mataix-Cols D, Caspi A, et al. Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am J Psychiatry. 2009;166(3):329-336. doi:10.176/api.ajp.208.0807106 PubMed
11. Fireman B, Koran LM, Leventhal JL, et al. The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization. Am J Psychiatry. 2001;158(11):1904-1910. doi:10.176/api.ajp.158.1. 1904 PubMed (Pubitemid 33054786)
12. Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143(4):437-441. PubMed (Pubitemid 16119747)
13. Cunill R, Castells X, Simeon D. Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry. 2009;70(1):70-82. doi:10.408/JCP.07r03618 PubMed
14. Poyurovsky M, Kriss V, Weisman G, et al. Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry. 2003;64(11):1300-1307. doi:10.408/JCP.v64n104 PubMed (Pubitemid 37490234)
15. Bottas A, Cooke RG, Richter MA. Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci. 2005;30(3):187-193. PubMed (Pubitemid 40942457)
16. Reznik I, Mester R, Kotler M, et al. Obsessive-compulsive schizophrenia: a new diagnostic entity? J Neuropsychiatry Clin Neurosci. 2001;13(1):115-116. doi:10.176/api.neuropsych.13.1.15 PubMed (Pubitemid 32151930)
17. Patel DD, Laws KR, Padhi A, et al. The neuropsychology of the schizoobsessive subtype of schizophrenia: a new analysis. Psychol Med. 2010;40(6):921-933. doi:10.1017/S03291709125 PubMed
18. Kim SW, Shin IS, Kim JM, et al. The 5-HT2 receptor profiles of antipsychotics in the pathogenesis of obsessive-compulsive symptoms in schizophrenia. Clin Neuropharmacol. 2009;32(4):224-226. doi:10.1097/WNF. 0b013e318184fafd PubMed
19. Mahendran R, Liew E, Subramaniam M. De novo emergence of obsessive-compulsive symptoms with atypical antipsychotics in Asian patients with schizophrenia or schizoaffective disorder: a retrospective, cross-sectional study. J Clin Psychiatry. 2007;68(4):542-545. doi:10.408/JCP.v68n0408 PubMed (Pubitemid 46663036)
20. Tibbo P, Warneke L. Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. J Psychiatry Neurosci. 1999;24(1):15-24. PubMed (Pubitemid 29107127)
21. Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs. 2004;18(14):989-1010. doi:10.2165/023210-20418140-04 PubMed (Pubitemid 39612010)
22. de Haan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry. 1999;60(6):364-365. doi:10.408/JCP.v60n0603 PubMed (Pubitemid 29289722)
23. Baker RW, Chengappa KN, Baird JW, et al. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992;53(12):439-442. PubMed (Pubitemid 23018087)
24. Patil VJ. Development of transient obsessive-compulsive symptoms during treatment with clozapine. Am J Psychiatry. 1992;149(2):272. PubMed
25. Patel B, Tandon R. Development of obsessive-compulsive symptoms during clozapine treatment. Am J Psychiatry. 1993;150(5):836. PubMed (Pubitemid 23137697)
26. Mukhopadhaya K, Krishnaiah R, Taye T, et al. Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern. J Psychopharmacol. 2009;23(1):6-13. doi:10.17/02698108089582 PubMed
27. Poyurovsky M, Hermesh H, Weizman A. Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients. Clin Neuropharmacol. 1996;19(4):305-313. doi:10.1097/02826-19619040-03 PubMed (Pubitemid 26250113)
28. Rahman MS, Grace JJ, Pato MT, et al. Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior. Am J Psychiatry. 1998;155(11):1629-1630. PubMed (Pubitemid 28512044)
29. Cassady SL, Thaker GK. Addition of fluoxetine to clozapine. Am J Psychiatry. 1992;149(9):1274. PubMed
30. Steingard S, Chengappa KN, Baker RW, et al. Clozapine, obsessive symptoms, and serotonergic mechanisms. Am J Psychiatry. 1993; 150(9):1435. PubMed (Pubitemid 23259595)
31. Biondi M, Fedele L, Arcangeli T, et al. Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine. Psychother Psychosom. 1999;68(2):111-112. doi:10.159/012321 PubMed (Pubitemid 29108141)
32. Mozes T, Toren P, Chernauzan N, et al. Clozapine treatment in very early onset schizophrenia. J Am Acad Child Adolesc Psychiatry. 1994;33(1):65-70. doi:10.1097/04583-194010-010 PubMed (Pubitemid 24017219)
33. Allen L, Tejera C. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline. Am J Psychiatry. 1994;151(7):1096-1097. PubMed (Pubitemid 24208654)
34. Suppes T, Rush AJ. Medication optimization during clozapine treatment. J Clin Psychiatry. 1996;57(7):307-308. PubMed
35. Levkovitch Y, Kronnenberg Y, Gaoni B. Can clozapine trigger OCD? J Am Acad Child Adolesc Psychiatry. 1995;34(3):263. doi:10.1097/04583-195030-05 PubMed
36. Ke CL, Yen CF, Chen CC, et al. Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature. Kaohsiung J Med Sci. 2004;20(6):295-301. doi:10.1016/S1607-51X(09) 70121-4 PubMed
37. Kopala L, Honer WG. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1994;151(11):1714-1715. PubMed (Pubitemid 24337610)
38. Alevizos B, Lykouras L, Zervas IM, et al. Risperidone-induced obsessive-compulsive symptoms: a series of six cases. J Clin Psychopharmacol. 2002;22(5):461-467. doi:10.1097/04714-20210-04 PubMed
39. Mahendran R. Obsessional symptoms associated with risperidone treatment. Aust N Z J Psychiatry. 1998;32(2):299-301. doi:10.3109/04867980906274 PubMed (Pubitemid 28211711)
40. Mahendran R. Obsessive-compulsive symptoms with risperidone. J Clin Psychiatry. 1999;60(4):261-263. doi:10.408/JCP.v60n0412b PubMed
41. Dodt JE, Byerly MJ, Cuadros C, et al. Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline. Am J Psychiatry. 1997;154(4):582. PubMed (Pubitemid 27147624)
42. Bakaras P, Georgoussi M, Liakos A. Development of obsessive and depressive symptoms during risperidone treatment. Br J Psychiatry. 1999;174(6):559. doi:10.192/bjp.174.6.59a PubMed
43. Alzaid K, Jones BD. A case report of risperidone-induced obsessive-compulsive symptoms. J Clin Psychopharmacol. 1997;17(1):58-59. doi:10.1097/04714-197020-014 PubMed (Pubitemid 27047267)
44. de Haan L, Beuk N, Hoogenboom B, et al. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. J Clin Psychiatry. 2002;63(2):104-107. doi:10.408/JCP.v63n0203 PubMed (Pubitemid 34173845)
45. Mottard JP, de la Sablonnière JF. Olanzapine-induced obsessive-compulsive disorder. Am J Psychiatry. 1999;156(5):799-800. PubMed
46. Morrison D, Clark D, Goldfarb E, et al. Worsening of obsessive-compulsive symptoms following treatment with olanzapine. Am J Psychiatry. 1998;155(6):855. PubMed (Pubitemid 28252672)
47. Lykouras L, Zervas IM, Gournellis R, et al. Olanzapine and obsessive-compulsive symptoms. Eur Neuropsychopharmacol. 2000;10(5):385-387. doi:10.1016/S0924-97X(0)096-1 PubMed
48. De Haan L, Oekeneva A, Van Amelsvoort T, et al. Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. Eur Psychiatry. 2004;19(8):524. doi:10.1016/j.eurpsy.204.09.02 PubMed (Pubitemid 39602782)
49. Ma N, Tan LW, Wang Q, et al. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms. Psychiatry Res. 2007;150(1):61-69. doi:10.1016/j.psychres.205.10.05 PubMed (Pubitemid 46281332)
50. Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11(7):622-632. doi:10.1038/sj.mp.401823 PubMed (Pubitemid 43989810)
51. van Nimwegen L, de Haan L, van Beveren N, et al. Obsessive-compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. J Clin Psychopharmacol. 2008;28(2):214-218. doi:10.1097/JCP.0b013e31816f520 PubMed
52. Baker RW, Ames D, Umbricht DS, et al. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo. Psychopharmacol Bull. 1996;32(1):89-93. PubMed (Pubitemid 26176207)
53. Korver N, Quee PJ, Boos HB, et al GROUP Investigators. Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods [published online ahead of print March 15, 2012]. Int J Methods Psychiatr Res. doi:10.102/mpr.1352 PubMed
54. Andreasen NC, Flaum M, Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry. 1992;49(8):615-623. doi:10.101/archpsyc.192.01820802304 PubMed
55. Wing JK, Babor T, Brugha T, et al. Schedules for Clinical Assessment in Neuropsychiatry. SCAN. Arch Gen Psychiatry. 1990;47(6):589-593. doi:10.101/archpsyc.190.0181018089012 PubMed (Pubitemid 20189971)
56. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 1: development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011. doi:10.101/archpsyc.1989.01810104807 PubMed (Pubitemid 19278229)
57. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale,2: validity. Arch Gen Psychiatry. 1989;46(11):1012-1016. doi:10.101/archpsyc.1989.01810105408 PubMed (Pubitemid 19278230)
58. de Haan L, Hoogeboom B, Beuk N, et al. Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale in schizophrenia patients. Psychopharmacol Bull. 2006;39(1):25-30. PubMed
59. Boyette L, Swets M, Meijer C, et al; GROUP authors. Factor structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive-compulsive symptoms. Psychiatry Res. 2011;186(2-3):409-413. PubMed
60. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276. PubMed (Pubitemid 18039085)
61. Peralta V, Cuesta MJ. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res. 1994;53(1):31-40. doi:10.1016/0165-1781(94)9093-0 PubMed (Pubitemid 24266119)
62. Ongür D, Goff DC. Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophr Res. 2005;75(2-3):349-362. doi:10.1016/j.schres.204.08.012 PubMed (Pubitemid 40693067)
63. Stein MB, Forde DR, Anderson G, et al. Obsessive-compulsive disorder in the community: an epidemiologic survey with clinical reappraisal. Am J Psychiatry. 1997;154(8):1120-1126. PubMed (Pubitemid 27328829)
64. Weissman MM, Bland RC, Canino GJ, et al The Cross National Collaborative Group. The cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry. 1994;55(suppl):5-10. PubMed (Pubitemid 24113069)
65. Fleischhaker C, Schulz E, Tepper K, et al. Long-term course of adolescent schizophrenia. Schizophr Bull. 2005;31(3):769-780. doi:10.1093/schbul/sbi014 PubMed (Pubitemid 41253325)
66. Perani D, Garibotto V, Gorini A, et al. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage. 2008;42(1):306-314. doi:10.1016/j.neuroimage.208.04.23 PubMed
67. Enoch MA, Kaye WH, Rotondo A, et al. 5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet. 1998;351(9118):1785-1786. doi:10.1016/S0140-6736(05)78746-8 PubMed (Pubitemid 28269194)
68. Arranz MJ, Munro J, Sham P, et al. Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophr Res. 1998;32(2):93-99. doi:10.1016/S0920-964(98)032-2 PubMed (Pubitemid 28364714)
69. Kapur S, Zipursky RB, Remington G, et al. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry. 1998;155(7):921-928. PubMed (Pubitemid 28307604)
70. Saxena S, Wang D, Bystritsky A, et al. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. J Clin Psychiatry. 1996;57(7):303-306. PubMed (Pubitemid 26251110)
71. Ramasubbu R, Ravindran A, Lapierre Y. Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. Pharmacopsychiatry. 2000;33(6):236-238. doi:10.105/s-20-8360 PubMed
72. Markianos M, Hatzimanolis J, Lykouras L, et al. Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine. Schizophr Res. 2002;56(1-2):11-17. doi:10.1016/S0920-964(01)021-3 PubMed (Pubitemid 34655462)
73. Reznik I, Yavin I, Stryjer R, et al. Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study. Pharmacopsychiatry. 2004;37(2):52-56. (Pubitemid 38651017)